Creative Biolabs, a provider of glycobiology research services, has announced expanded capabilities in custom oligosaccharide synthesis and comprehensive glycan characterization to support drug discovery and biomedical research. As glycan-based therapeutics, vaccines, and biomarker studies gain momentum, researchers increasingly require structurally defined oligosaccharides supported by reliable analytical validation. Oligosaccharides play critical roles in cell signaling, immune regulation, pathogen-host interactions, and disease progression, making them valuable tools for therapeutic, vaccine, and diagnostic research. However, their structural complexity continues to complicate synthesis, purification, and characterization.
To address these challenges, Creative Biolabs combines advanced chemical, enzymatic, and chemoenzymatic synthesis technologies with comprehensive glycan analysis platforms, enabling researchers to obtain highly characterized oligosaccharides with greater efficiency and confidence. “The structural complexity of oligosaccharides continues to present significant challenges for researchers developing next-generation therapeutics,” said a scientist from Creative Biolabs. “By integrating custom synthesis with comprehensive analytical characterization, we help researchers obtain structurally validated glycans that support reliable downstream studies and accelerate scientific discovery.”
Researchers utilizing Creative Biolabs' glycan services have highlighted both the quality of the synthesized products and the comprehensive technical support provided throughout their projects. In one recent project, researchers required a complex glycan structure that was not readily available through standard commercial sources. Integrated synthesis and analytical characterization helped support downstream structural confirmation.
Creative Biolabs offers a broad portfolio of custom oligosaccharide and glycan analysis services to support diverse research applications. These include custom oligosaccharide synthesis of high-purity oligosaccharides, complex glycans, tumor-associated carbohydrate antigens (TACAs), and functionalized carbohydrate derivatives; advanced glycan characterization using mass spectrometry (MS), high-performance liquid chromatography (HPLC), and nuclear magnetic resonance (NMR) to determine glycan structures, linkage patterns, sequences, and purity; and application-oriented carbohydrate design for structural biology, glycoprotein research, biomarker discovery, immunology, targeted drug delivery, and therapeutic development.
By combining custom carbohydrate synthesis with rigorous analytical characterization under one integrated platform, Creative Biolabs helps researchers reduce technical risks, improve experimental reproducibility, support more efficient project progression, and accelerate scientific innovation. Researchers can explore customized oligosaccharide synthesis and glycan characterization options through Creative Biolabs' glycobiology platform. Visit https://www.creative-biolabs.com/glycoprotein/.
